Investment
Features
FeesSafety
Academy
More
Pluang+

Solana delays Alpenglow upgrade to October, aiming for 150ms finality from 12.8s today

Protocol Fundamentals
14 Aug 2026
Crypto news
View Source
Bullish
Solana delays Alpenglow upgrade to October, aiming for 150ms finality from 12.8s today

Solana plans to replace its TowerBFT consensus with Alpenglow, targeting a finality time of about 150 milliseconds, significantly faster than the current 12.8 seconds. The upgrade, initially expected in September 2026, is now scheduled for October 2026 with the Agave 4.3 release. Alpenglow aims to improve transaction finality, which is crucial for exchanges and payments, by providing stronger certainty that transactions cannot be reversed. Testing and security reviews are ongoing, including a bug bounty program offering up to 50,000 SOL to ensure readiness before mainnet deployment.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
50 minutes ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
1 hour ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
2 hours ago
NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...

Analyst Insights
Bullish
3 hours ago
Nelnet Business Services acquires Indian school tech firm Entab to expand in K-12 education market.

Nelnet Business Services acquires Indian school tech firm Entab to expand in K-12 education market.

Nelnet Business Services (NBS) has acquired Entab Infotech, a leading Indian provider of school administration and learning technology software. This acquisition supports NBS's international growth strategy by entering India’s large K-12 education ma...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App